(VOYAGER) Study of Avapritinib vs Regorafenib in Patients With Locally Advanced Unresectable or Metastatic GIST

NCT03465722 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

476

Enrollment

INDUSTRY

Sponsor class

Conditions

GIST

Interventions

DRUG: avapritinib
DRUG: regorafenib

Sponsor

Blueprint Medicines Corporation